Share

February 24, 2015; 84 (8) Video NeuroImages

Congenital mirror movements

From piano player to opera singer

Aurélie Méneret, Quentin Welniarz, Oriane Trouillard, Emmanuel Roze
First published February 23, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001290
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
729

Share

Article Information

vol. 84 no. 8 860
DOI: 
https://doi.org/10.1212/WNL.0000000000001290
PubMed: 
25713113
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published February 23, 2015.
Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Aurélie Méneret, MD,
    2. Quentin Welniarz, MS,
    3. Oriane Trouillard and
    4. Emmanuel Roze, MD, PhD
  1. Aurélie Méneret, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Association des Assistants et Internes en Neurologie de France (ANAINF), funding for travel to conference (2) Journ?es de Neurologie en Langue Fran?aise (JNLF), funding for travel to conference (3) European Federation of the Neurological Societies, funding for travel to conference

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Quentin Welniarz, MS,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Oriane Trouillard and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Emmanuel Roze, MD, PhD
    5. Scientific Advisory Boards:

    1. served on scientific advisory boards for ORKYN, IPSEN, and MERZ-pharma

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. received travel funding from TEVA Pharma, Novartis, the Dystonia Coalition, the Movement Disorders Society, the World Federation of Neurology Association of Parkinsonism and Related Disorders,the International Federation of Clinical Neurophysiology. . He also received speech honorarium from Novartis, Teva and Orkyn.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. received research support from Ipsen, Merz-Pharma, Novartis, Teva, Lundbeck, Orkyn

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Dr. Roze is the recipient of a grant ?poste d?accueil? AP-HP/CNRS. He received research support from INSERM (COSSEC), AP-HP (DRC-PHRC)

    Research Support, Foundations and Societies:

    1. received research support from Fondation pour la Recherche sur le Cerveau (FRC), the Dystonia Coalition (Pilot project)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From Inserm (A.M., Q.W., O.T., E.R.), U 1127; CNRS (A.M., Q.W., O.T., E.R.), UMR 7225; Sorbonne Universités (A.M., Q.W., O.T., E.R.), UPMC Univ Paris 06, UMR S 1127; Institut du Cerveau et de la Moelle épinière (A.M., Q.W., O.T., E.R.), ICM; AP-HP (A.M., E.R.), Département de Neurologie, Hôpital de la Pitié Salpêtrière; and Neuroscience Paris Seine (Q.W.), CNRS UMR8246, Inserm U1130, Paris, France.
  1. Correspondence to Dr. Roze: emmanuel.flamand-roze{at}psl.aphp.fr
View Abstract

Article usage

Article usage: February 2015 to November 2023

AbstractFullPdfSource
Feb 20152925166Highwire
Mar 20152146648Highwire
Apr 201537108Highwire
May 201541109Highwire
Jun 201524142Highwire
Jul 201524169Highwire
Aug 20152064Highwire
Sep 201512154Highwire
Oct 20151048Highwire
Nov 201512149Highwire
Dec 20151233Highwire
Jan 201671515Highwire
Feb 2016231517Highwire
Mar 20161659Highwire
Apr 2016934Highwire
May 201612710Highwire
Jun 20161666Highwire
Jul 201651110Highwire
Aug 201619812Highwire
Sep 20161495Highwire
Oct 2016161314Highwire
Nov 20161724Highwire
Dec 20161145Highwire
Jan 20171391Highwire
Feb 20171784Highwire
Mar 201710145Highwire
Apr 2017731Highwire
May 2017776Highwire
Jun 20171052Highwire
Jul 2017254Highwire
Aug 2017212Highwire
Sep 2017844Highwire
Oct 2017745Highwire
Nov 2017355Highwire
Dec 2017060Highwire
Jan 201862110Highwire
Feb 20180182Highwire
Mar 20184176Highwire
Apr 20181131Highwire
May 2018243Highwire
Jun 20180121Highwire
Jul 20181121Highwire
Aug 2018091Highwire
Sep 20182151Highwire
Oct 20182113Highwire
Nov 2018281Highwire
Dec 2018061Highwire
Jan 20190192Highwire
Feb 20190102Highwire
Mar 201911510Highwire
Apr 201911011Highwire
May 20191316Highwire
Jun 20192207Highwire
Jul 20193188Highwire
Aug 20190113Highwire
Sep 20190173Highwire
Oct 20191296Highwire
Nov 20192187Highwire
Dec 20191231Highwire
Jan 20201223Highwire
Feb 20200169Highwire
Mar 20201254Highwire
Apr 20203648Highwire
May 20200145Highwire
Jun 20205173Highwire
Jul 20201160Highwire
Aug 2020084Highwire
Sep 20200217Highwire
Oct 20201339Highwire
Nov 20202255Highwire
Dec 20201163Highwire
Jan 20211185Highwire
Feb 20211189Highwire
Mar 20215224Highwire
Apr 202163217Highwire
May 20211165Highwire
Jun 202122810Highwire
Jul 20211269Highwire
Aug 20212397Highwire
Sep 20212225Highwire
Oct 202132425Highwire
Nov 202122617Highwire
Dec 20210396Highwire
Jan 20220175Highwire
Feb 20220134Highwire
Mar 20222158Highwire
Apr 20222147Highwire
May 202231110Highwire
Jun 20220145Highwire
Jul 2022041Highwire
Aug 2022013Highwire
Sep 20220815Highwire
Oct 20225119Highwire
Nov 20221197Highwire
Dec 2022091Highwire
Jan 20230313Highwire
Feb 20230201Highwire
Mar 20232143Highwire
Apr 20230127Highwire
May 20232114Highwire
Jun 20230122Highwire
Jul 20231188Highwire
Aug 202321512Highwire
Sep 202301413Highwire
Oct 20230103Highwire
Nov 20230122Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles